Drug Trial Radar · NCT05628389
Phone Enabled Implementation of Cessation Support
Last checked: Nov 20, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,500
Planned (sponsor's estimate)
Start
Mar 6, 2024
Primary completion
Aug 30, 2027
Study completion Aug 31, 2027
Sponsor
- Lead sponsor
- University of FloridaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Nov 28, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The tobacco use burden in Lebanon is exceptionally high: 35% of adults are current cigarette smokers and 39% are current waterpipe smokers. Although the World Health Organization endorses evidence-based interventions for population-level tobacco dependence treatment, recommended treatments are not integrated as a routine part of primary care in Lebanon, as is the case in other low-resource settings. The objective of this proposal is to evaluate the comparative effectiveness of promising multi-component interventions for implementing evidence-based cessation treatment in Lebanon's national system of primary health care centers.
Conditions
- Smoking Cessation
Interventions
Educational materialsBehavioral
Patient educational materials to address insufficient knowledge about harms of tobacco use and cessation.
Phone counselingBehavioral
Cessation counseling to address insufficient patient self-efficacy and motivation.
Nicotine Replacement TherapyDrug
Nicotine patches to address nicotine withdrawal symptoms in patients.
Provider trainingBehavioral
Provider training to address insufficient knowledge and self-efficacy to deliver AAA/AAC to patients.
Electronic remindersBehavioral
Electronic reminders to address the lack of integration of AAA/AAC into practice.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 7-day smoking abstinenceTime frame: 6 Months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
American University of Beirut Medical Center
Beirut, Lebanon · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.